Nav: Home

Compact drug synthesizer could revolutionize drug delivery

March 31, 2016

Researchers have developed a system the size of a household fridge that can synthesize a variety of pharmaceuticals in short periods of time, including an antihistamine, an antidepressant, a common local anesthetic, and a central nervous system depressant. Pharmaceutical manufacturing often requires multiple compounds and steps of synthesis at different sites, making the production process slow, inefficient and cumbersome. This disjointed process means that pharmaceuticals are often produced in batches, a main contributing factor to drug shortages. The condensed system developed by Andrea Adamo and colleagues offers continuous production of a drug - from start to finish - over the course of several hours or days, at a quality that meets U.S. Pharmacopeial standards. This advancement holds numerous important implications, such as for drug delivery in the face of disease epidemics or after natural disasters. The system consists of reconfigurable units that can be added or removed depending on the drug being synthesized. As proof of principle, the researchers demonstrate the production of diphenhydramine hydrochloride (common trade name Benadryl®, often used to treat allergies), lidocaine hydrochloride (a common local anesthetic and antiarrhythmic drug), diazepam (commonly known as Valium®), and fluoxetine hydrochloride (a widely used antidepressant, e.g. Prozac®). The synthesizer was able to produce 4500, 810, 3000 and 1100 doses per day, respectively. Switching production from the simplest to the most complex drug took two hours. The system currently only produces liquid forms of drugs, but the authors note that new approaches, such as three-dimensional printing, could facilitate on-the-spot production of pharmaceuticals in pill form. A Perspective by Rainer Martin discusses this development in more detail, highlighting the scientific advantages that the system has by harnessing flow processes.
-end-


American Association for the Advancement of Science

Related Antidepressant Articles:

Analysis examines safety of antidepressant use during pregnancy
Use of fluoxetine -- the most commonly prescribed antidepressant -- during pregnancy is linked with a slightly increased risk of malformations in infants, according to a recent analysis of published studies.
Antidepressant may enhance drug delivery to the brain
New research from the National Institutes of Health found that pairing the antidepressant amitriptyline with drugs designed to treat central nervous system diseases, enhances drug delivery to the brain by inhibiting the blood-brain barrier in rats.
Novel mode of antidepressant action may help patients unresponsive to SSRIs
Research at Osaka University identified a novel mode of action for a potential antidepressant that also leads to nerve cell growth in the mouse hippocampus.
Antidepressant use during pregnancy not associated with increased risk of autism, ADHD in children
Two studies published by JAMA examine the risk of autism and other adverse birth outcomes among women who use antidepressants during pregnancy.
Most off-label antidepressant prescriptions lack strong scientific evidence
Most off-label antidepressant prescriptions lack strong scientific evidence, finds a study published by The BMJ today.
Brain scan before antidepressant therapy may predict response
A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a new study published in the journal Brain.
Antidepressant use increases hip fracture risk among elderly
Antidepressant use nearly doubles the risk of hip fracture among community-dwelling persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Antidepressant effects of ketamine
New preclinical evidence was put forward by investigators in a series of presentations at the recent meeting of the American College of Neuropsychopharmacology suggest that the a metabolite of ketamine can produce antidepressant-like effects in a mouse model of depression.
New strategy for antidepressant therapies
Activated subclass of nerve cells producing GABA neurotransmitter have been discovered to have antidepressant effects similar to pharmaceutical antidepressants in depressed mice, giving new hope that GABA-enhancing drugs could be rapidly acting and more effective antidepressants.
Is sufficient sleep the key to successful antidepressant response?
Antidepressants are necessary for many with major depressive disorder, but response times and remission rates are a problem.

Related Antidepressant Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".